HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
Recruitment unclearEUCTR 2016-002875-81

Bumetanide for the Autism Spectrum Clinical Effectiveness Trial

This historical record does not confirm current site availability.

Historical research recordNetherlandsADHD
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Netherlands
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Enrollment listed in the registry
Not clearly listed
Sponsor
UMC Utrecht
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Netherlands
Age range
Not clearly listed
Official registry ID
EUCTR 2016-002875-81
Official title
Show the full official title

Bumetanide for the Autism Spectrum Clinical Effectiveness Trial

Recruitment & locations

Status unknown

Netherlands

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is UMC Utrecht.

Want to explore more studies?

Explore studies